United States - English - NLM (National Library of Medicine)

remedyrepack inc. - itraconazole (unii: 304nug5gf4) (itraconazole - unii:304nug5gf4) - itraconazole capsules    are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: 1. blastomycosis, pulmonary and extrapulmonary 2. histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non- meningeal histoplasmosis, and 3. aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin b therapy. specimens for fungal cultures and other relevant laboratory studies (wet mount, histopathology, serology) should be obtained before therapy to isolate and identify causative organisms. therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, antiinfective therapy should be adjusted accordingly. itraconazole capsules    are also indicated for the treatment of the following fungal infections in non-immunocompromised patients:  1. onyc

United States - English - NLM (National Library of Medicine)

natco pharma usa llc - itraconazole (unii: 304nug5gf4) (itraconazole - unii:304nug5gf4) - itraconazole oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis. (see clinical pharmacology: special populations, warnings, and adverse reactions: post-marketing experience for more information.) itraconazole oral solution should not be administered to patients with evidence of ventricular dysfunction such as congestive heart failure (chf) or a history of chf except for the treatment of life-threatening or other serious infections. (see boxed warning, warnings, precautions: drug interactions-calcium channel blockers, adverse reactions: post-marketing experience, and clinical pharmacology: special populations.) coadministration of a number of cyp3a4 substrates are contraindicated with itraconazole. plasma concentrations increase for the following drugs: levaceytlmethadol (levomethadyl), methadone, disopyramide, dofetilide, dronedarone, quinidine, isavuconazole, ergot alkaloids (such as dihydroergotamine, ergometrine (ergonovine), ergotamine, methylergometrine (methylergono

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - itraconazole - capsule - triazole derivatives; itraconazole

Israel - English - Ministry of Health

sanofi israel ltd - duvelisib - capsules - duvelisib - 15 mg - lurbinectedin - copiktra is a kinase inhibitor indicated for the treatment of adult patients with:• relapsed or refractory chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll) after at least two prior therapies.• relapsed or refractory follicular lymphoma (fl) after at least two prior systemic therapies.

Israel - English - Ministry of Health

sanofi israel ltd - duvelisib - capsules - duvelisib - 25 mg - lurbinectedin - copiktra is a kinase inhibitor indicated for the treatment of adult patients with:• relapsed or refractory chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll) after at least two prior therapies.• relapsed or refractory follicular lymphoma (fl) after at least two prior systemic therapies.